CH591456A5 - - Google Patents

Info

Publication number
CH591456A5
CH591456A5 CH1305773A CH1305773A CH591456A5 CH 591456 A5 CH591456 A5 CH 591456A5 CH 1305773 A CH1305773 A CH 1305773A CH 1305773 A CH1305773 A CH 1305773A CH 591456 A5 CH591456 A5 CH 591456A5
Authority
CH
Switzerland
Application number
CH1305773A
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Priority to CH1305773A priority Critical patent/CH591456A5/xx
Priority to AR255569A priority patent/AR207764A1/es
Priority to YU02178/74A priority patent/YU217874A/xx
Priority to ZA00745317A priority patent/ZA745317B/xx
Priority to IL45510A priority patent/IL45510A/xx
Priority to CA207,509A priority patent/CA1037476A/en
Priority to AU72631/74A priority patent/AU484442B2/en
Priority to FI2561/74A priority patent/FI58638C/fi
Priority to NL7411685.A priority patent/NL155827B/xx
Priority to DK468374AA priority patent/DK135683B/da
Priority to PL1974195308A priority patent/PL99159B1/pl
Priority to PL1974173909A priority patent/PL97757B1/pl
Priority to IE1870/74A priority patent/IE40523B1/xx
Priority to IE1982/77A priority patent/IE40524B1/xx
Priority to PH16253A priority patent/PH10643A/en
Priority to SE7411382A priority patent/SE419443B/sv
Priority to IE1983/77A priority patent/IE40525B1/xx
Priority to JP49103536A priority patent/JPS6042238B2/ja
Priority to DD181015A priority patent/DD116824A5/xx
Priority to FR7430568A priority patent/FR2242984B1/fr
Priority to DD190238A priority patent/DD122785A5/xx
Priority to LU70878A priority patent/LU70878A1/xx
Priority to GB39617/74A priority patent/GB1484481A/en
Priority to NO743271A priority patent/NO140858C/no
Priority to HUHO1718A priority patent/HU170427B/hu
Priority to CU34115A priority patent/CU34115A/es
Priority to ES429949A priority patent/ES429949A1/es
Priority to SU7402058406A priority patent/SU577987A3/ru
Priority to GB47894/76A priority patent/GB1484483A/en
Priority to AT735174A priority patent/AT338797B/de
Priority to BE148396A priority patent/BE819773A/xx
Priority to GB47893/76A priority patent/GB1484482A/en
Priority to BR7614/74A priority patent/BR7407614D0/pt
Priority to DE2443682A priority patent/DE2443682C2/de
Priority to ES437013A priority patent/ES437013A1/es
Priority to ES437012A priority patent/ES437012A1/es
Priority to ES437009A priority patent/ES437009A1/es
Priority to ES437008A priority patent/ES437008A1/es
Priority to ES437007A priority patent/ES437007A1/es
Priority to ES437011A priority patent/ES437011A1/es
Priority to SU752145937A priority patent/SU609465A3/ru
Priority to SU7502145932A priority patent/SU571189A3/ru
Priority to AR259408A priority patent/AR211387Q/es
Priority to DK304476A priority patent/DK304476A/da
Priority to AT949276A priority patent/AT351034B/de
Publication of CH591456A5 publication Critical patent/CH591456A5/xx
Priority to YU3016/80A priority patent/YU37154B/xx
Priority to YU3015/80A priority patent/YU37153B/xx
Priority to HK1/81A priority patent/HK181A/xx
Priority to US06/279,106 priority patent/US4515948A/en
Priority to US06/706,227 priority patent/US4659818A/en
Priority to US07/003,095 priority patent/US4792557A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/325—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals directly attached to the ring nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/325—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals directly attached to the ring nitrogen atom
    • C07D207/327—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/48—Two nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/48—Two nitrogen atoms
    • C07D239/49—Two nitrogen atoms with an aralkyl radical, or substituted aralkyl radical, attached in position 5, e.g. trimethoprim
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D295/155—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyrrole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
CH1305773A 1973-09-12 1973-09-12 CH591456A5 (sv)

Priority Applications (51)

Application Number Priority Date Filing Date Title
CH1305773A CH591456A5 (sv) 1973-09-12 1973-09-12
AR255569A AR207764A1 (es) 1973-09-12 1974-01-01 Procedimiento para preparar nuevos derivados de 2,4-diamino-5-(3,4,5-bencil substituidas)-1,3-diazinas
YU02178/74A YU217874A (en) 1973-09-12 1974-08-06 Process for obtaining new 2,4-diaminobenzyl-pyrimidines
ZA00745317A ZA745317B (en) 1973-09-12 1974-08-19 Novel benzylpyrimidines
IL45510A IL45510A (en) 1973-09-12 1974-08-21 2,4-diamino-5-(4-aminobenzyl)-pyrimidine derivatives,their manufacture and antibacterial compositions containing them
CA207,509A CA1037476A (en) 1973-09-12 1974-08-21 Benzylpyrimidines
AU72631/74A AU484442B2 (en) 1973-09-12 1974-08-23 Novel benzylpyrimidines
FI2561/74A FI58638C (fi) 1973-09-12 1974-09-02 Foerfarande foer framstaellning av antibakteriellt verksamma 2,4-diamino-5-bensylpyrimidiner och salter daerav
NL7411685.A NL155827B (nl) 1973-09-12 1974-09-03 Werkwijze voor de bereiding van antibacterieel werkzame benzylpyrimidinen, alsmede voor de bereiding van antibacterieel werkzame preparaten, die deze verbindingen bevatten, en de gevormde preparaten.
DK468374AA DK135683B (da) 1973-09-12 1974-09-04 Analogifremgangsmåde til fremstilling af 2,4-diamino-5-benzyl-pyrimidinderivater eller salte af disse forbindelser.
PL1974195308A PL99159B1 (pl) 1973-09-12 1974-09-06 Sposob wytwarzania nowych benzylopirymidyn
PL1974173909A PL97757B1 (pl) 1973-09-12 1974-09-06 Sposob wytwarzania nowych benzylopirymidyn
IE1870/74A IE40523B1 (en) 1973-09-12 1974-09-09 Novel benzylpyrimidines
IE1982/77A IE40524B1 (en) 1973-09-12 1974-09-09 -cyano-hydrocinnamaldehyde acetals
PH16253A PH10643A (en) 1973-09-12 1974-09-09 Benzylpyrimidine derivatives and pharmaceutical compositions thereof
SE7411382A SE419443B (sv) 1973-09-12 1974-09-09 Forfarande for framstellning av nya 2,4 diamino-5-bensylpyrimidinderivat
IE1983/77A IE40525B1 (en) 1973-09-12 1974-09-09 Hydrocinnamic acid nitriles
JP49103536A JPS6042238B2 (ja) 1973-09-12 1974-09-10 ベンジルピリミジンの製造方法
DD181015A DD116824A5 (sv) 1973-09-12 1974-09-10
FR7430568A FR2242984B1 (sv) 1973-09-12 1974-09-10
DD190238A DD122785A5 (sv) 1973-09-12 1974-09-10
LU70878A LU70878A1 (sv) 1973-09-12 1974-09-10
GB39617/74A GB1484481A (en) 1973-09-12 1974-09-11 Benzylpyrimidine derivatives
NO743271A NO140858C (no) 1973-09-12 1974-09-11 Analogifremgangsmaate ved fremstilling av terapeutisk aktive nye 2,4-diamino-5-benzyl-pyrimidinderivater
HUHO1718A HU170427B (sv) 1973-09-12 1974-09-11
CU34115A CU34115A (es) 1973-09-12 1974-09-11 Nuevas bencilpirimidinas
ES429949A ES429949A1 (es) 1973-09-12 1974-09-11 Un procedimiento para la preparacion de derivados de ben- cilpirimidina.
SU7402058406A SU577987A3 (ru) 1973-09-12 1974-09-11 Способ получени бензилпиримидинов или их солей
GB47894/76A GB1484483A (en) 1973-09-12 1974-09-11 Alpha-cyano hydrocinnamaldehyde acetals
AT735174A AT338797B (de) 1973-09-12 1974-09-11 Verfahren zur herstellung von neuen benzylpyrimidinen und deren salzen
BE148396A BE819773A (fr) 1973-09-12 1974-09-11 Nouvelles benzylpyrimidines
GB47893/76A GB1484482A (en) 1973-09-12 1974-09-11 Hydrocinnamic acid nitriles
BR7614/74A BR7407614D0 (pt) 1973-09-12 1974-09-12 Processo para preparar derivador de benzil-pirimidina e compostos assim obtidos
DE2443682A DE2443682C2 (de) 1973-09-12 1974-09-12 Neue 2,4-Diamino-5-benzylpyrimidine
ES437013A ES437013A1 (es) 1973-09-12 1975-04-25 Un procedimiento para la preparacion de derivados de bencil-pirimidina.
ES437012A ES437012A1 (es) 1973-09-12 1975-04-25 Un procedimiento para la preparacion de derivados de bencil-pirimidina.
ES437009A ES437009A1 (es) 1973-09-12 1975-04-25 Un procedimiento para la preparacion de derivados de bencil-pirimidina.
ES437008A ES437008A1 (es) 1973-09-12 1975-04-25 Un procedimiento para la preparacion de derivados de bencil-pirimidina.
ES437007A ES437007A1 (es) 1973-09-12 1975-04-25 Procedimiento para la preparacion de derivados de bencilpi- rimidina.
ES437011A ES437011A1 (es) 1973-09-12 1975-04-25 Un procedimiento para la preparacion de derivados de bencil-pirimidina.
SU752145937A SU609465A3 (ru) 1973-09-12 1975-06-20 Способ получени проивзодных бензилпиримидина или их солей
SU7502145932A SU571189A3 (ru) 1973-09-12 1975-06-20 Способ получени бензилпиримидинов или их солей
AR259408A AR211387Q (es) 1973-09-12 1975-06-30 Procedimiento para obtener derivados de 2,4-diamina -5- (3, 4, 5- bencil sustituidos) -1, 3-diazinas
DK304476A DK304476A (da) 1973-09-12 1976-07-05 Benzylpyrimidiner, deres fremstilling og anvendelse
AT949276A AT351034B (de) 1973-09-12 1976-12-21 Verfahren zur herstellung von neuen benzyl- pyrimidinen und deren salzen
YU3016/80A YU37154B (en) 1973-09-12 1980-11-27 Process for obtaining new 2,4-diaminobenzyl-pyrimidines
YU3015/80A YU37153B (en) 1973-09-12 1980-11-27 Process for obtaining new 2,4-diaminobenzyl-pyrimidines
HK1/81A HK181A (en) 1973-09-12 1981-01-08 Benzylpyrimidine derivatives
US06/279,106 US4515948A (en) 1973-09-12 1981-06-30 2,4-Diamino-5-(4-amino and 4-dimethylamino-3,5-dimethoxy benzyl)pyrimidines
US06/706,227 US4659818A (en) 1973-09-12 1985-02-27 Intermediates for benzylpyrimidines
US07/003,095 US4792557A (en) 1973-09-12 1987-01-14 2,4-diamino-5[4-amino (or dimethylamino)-3,5-dimethoxybenzyl]pyrimidine and antibacterial composition thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH1305773A CH591456A5 (sv) 1973-09-12 1973-09-12

Publications (1)

Publication Number Publication Date
CH591456A5 true CH591456A5 (sv) 1977-09-15

Family

ID=4388903

Family Applications (1)

Application Number Title Priority Date Filing Date
CH1305773A CH591456A5 (sv) 1973-09-12 1973-09-12

Country Status (28)

Country Link
JP (1) JPS6042238B2 (sv)
AR (2) AR207764A1 (sv)
AT (1) AT338797B (sv)
BE (1) BE819773A (sv)
BR (1) BR7407614D0 (sv)
CA (1) CA1037476A (sv)
CH (1) CH591456A5 (sv)
CU (1) CU34115A (sv)
DD (2) DD116824A5 (sv)
DE (1) DE2443682C2 (sv)
DK (1) DK135683B (sv)
ES (7) ES429949A1 (sv)
FI (1) FI58638C (sv)
FR (1) FR2242984B1 (sv)
GB (3) GB1484483A (sv)
HK (1) HK181A (sv)
HU (1) HU170427B (sv)
IE (1) IE40523B1 (sv)
IL (1) IL45510A (sv)
LU (1) LU70878A1 (sv)
NL (1) NL155827B (sv)
NO (1) NO140858C (sv)
PH (1) PH10643A (sv)
PL (2) PL99159B1 (sv)
SE (1) SE419443B (sv)
SU (3) SU577987A3 (sv)
YU (3) YU217874A (sv)
ZA (1) ZA745317B (sv)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4515948A (en) * 1973-09-12 1985-05-07 Hoffmann-La Roche Inc. 2,4-Diamino-5-(4-amino and 4-dimethylamino-3,5-dimethoxy benzyl)pyrimidines
JPS5481278A (en) * 1977-10-18 1979-06-28 Wellcome Found Manufacture of triiseccaminomethane
CH639273A5 (de) 1978-09-12 1983-11-15 Hoffmann La Roche Diuretische mittel.
DE3250132C2 (de) * 1981-11-09 1997-01-16 Mallinckrodt Veterinary Inc Verfahren zur Herstellung von 2,4-Diamino-5-benzyl-pyrimidinen und neue Zwischenprodukte des Verfahrens
FR2516081B1 (fr) * 1981-11-09 1987-05-29 Wellcome Found Synthese de benzylpyrimidines et produits intermediaires pour cette synthese
GB2180836A (en) * 1985-09-27 1987-04-08 William James Stephen Barker Sunscreen
JPH0431685Y2 (sv) * 1987-06-01 1992-07-30
US4900859A (en) * 1987-12-03 1990-02-13 Hoffman-La Roche Inc. Process for 4-dimethylamino-3,5-dimethoxybenzaldehyde
CA1300166C (en) * 1987-12-03 1992-05-05 Alfredo Guerrato Process for the preparation of a benzoic acid ester

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1103931B (de) * 1957-02-21 1961-04-06 Wellcome Found Verfahren zur Herstellung von 2, 4-Diamino-5-benzylpyrimidinderivaten
US3485840A (en) * 1964-11-12 1969-12-23 Hoffmann La Roche 2,4-diamino - 5 - (2',4',5'-substituted benzyl) pyrimidines,intermediates and processes

Also Published As

Publication number Publication date
BE819773A (fr) 1975-03-11
FI256174A (sv) 1975-03-13
AT338797B (de) 1977-09-12
AR207764A1 (es) 1976-10-29
YU217874A (en) 1982-06-18
IE40523L (en) 1975-03-12
NO140858B (no) 1979-08-20
SU609465A3 (ru) 1978-05-30
FI58638C (fi) 1981-03-10
ATA735174A (de) 1977-01-15
CU21022L (en) 1981-09-09
FR2242984A1 (sv) 1975-04-04
IL45510A0 (en) 1974-11-29
YU301580A (en) 1983-04-27
AR211387Q (es) 1977-12-15
ES437008A1 (es) 1977-04-01
IL45510A (en) 1978-08-31
DK135683B (da) 1977-06-06
DK468374A (sv) 1975-05-12
FI58638B (fi) 1980-11-28
SU571189A3 (ru) 1977-08-30
YU301680A (en) 1983-04-27
ES437012A1 (es) 1977-04-01
ES437009A1 (es) 1977-04-01
ES429949A1 (es) 1976-10-01
BR7407614D0 (pt) 1975-07-08
JPS6042238B2 (ja) 1985-09-20
ES437013A1 (es) 1977-04-01
HU170427B (sv) 1977-06-28
PL97757B1 (pl) 1978-03-30
PH10643A (en) 1977-07-22
AU7263174A (en) 1976-02-26
GB1484481A (en) 1977-09-01
GB1484482A (en) 1977-09-01
CU34115A (es) 1983-10-04
DE2443682C2 (de) 1983-11-10
IE40523B1 (en) 1979-06-20
NO140858C (no) 1979-11-28
SE7411382L (sv) 1975-03-13
LU70878A1 (sv) 1976-08-19
NL7411685A (nl) 1975-03-14
NO743271L (sv) 1975-04-07
ES437011A1 (es) 1977-04-01
YU37154B (en) 1984-08-31
PL99159B1 (pl) 1978-06-30
HK181A (en) 1981-01-16
NL155827B (nl) 1978-02-15
YU37153B (en) 1984-08-31
FR2242984B1 (sv) 1977-11-04
DE2443682A1 (de) 1975-03-20
ZA745317B (en) 1975-11-26
DD122785A5 (sv) 1976-11-05
DK135683C (sv) 1977-11-14
GB1484483A (en) 1977-09-01
SE419443B (sv) 1981-08-03
DD116824A5 (sv) 1975-12-12
CA1037476A (en) 1978-08-29
SU577987A3 (ru) 1977-10-25
ES437007A1 (es) 1977-04-01
JPS5053385A (sv) 1975-05-12

Similar Documents

Publication Publication Date Title
AR201758A1 (sv)
AU476761B2 (sv)
AU465372B2 (sv)
AR201235Q (sv)
AR201231Q (sv)
AU474593B2 (sv)
AU474511B2 (sv)
AU474838B2 (sv)
AU465453B2 (sv)
AU465434B2 (sv)
AU471343B2 (sv)
AU450229B2 (sv)
AU476714B2 (sv)
NO743271L (sv)
AR201229Q (sv)
AU472848B2 (sv)
AU466283B2 (sv)
AU476696B2 (sv)
AR199451A1 (sv)
AU477823B2 (sv)
AU477824B2 (sv)
AU461342B2 (sv)
AU447540B2 (sv)
AR195948A1 (sv)
AR195311A1 (sv)

Legal Events

Date Code Title Description
PUE Assignment

Owner name: F. HOFFMANN-LA ROCHE AG

PL Patent ceased